Characterization of In Vitro Synthesized Equine Metabolites of the Selective Androgen Receptor Modulators S24 and S4

Journal of Equine Veterinary Science

Volumn 32, Issue 9, 2012, Pages 562-568

  Krug, Oliver ^a   Thomas, Andreas ^a   Beuck, Simon ^a   Schenk, Ina ^a   Machnik, Marc ^a   Schänzer, Wilhelm ^a   Bondesson, Ulf ^b,c   Hedeland, Mikael ^b,c   Thevis, Mario ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c Analytical Pharmaceutical Chemistry   (Sweden)

Author keywords

Equine; In vitro; LC MS; Metabolism; SARM

Indexed keywords

CANIS FAMILIARIS; EQUIDAE; RATTUS;

EID: 84865801112     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jevs.2012.01.005     Document Type: Article

References (18)

1. Chen J., Kim J., Dalton J.T. Discovery and therapeutic promise of selective androgen receptor modulators. Mol Interv 2005, 5:173-188.
2. Hijazi R.A., Cunningham G.R. Andropause: is androgen replacement therapy indicated for the aging male?. Annu Rev Med 2005, 56:117-137.
3. Dalton J.T., Mukherjee A., Zhu Z., Kirkovsky L., Miller D.D. Discovery of nonsteroidal androgens. Biochem Biophys Res Comm 1998, 244:1-4.
4. Mohler M.L., Bohl C.E., Jones A., Coss C.C., Narayanan R., He Y., et al. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 2009, 52:3597-3617.
5. Thevis M., Schänzer W. Mass spectrometry of selective androgen receptor modulators. J Mass Spectrom 2008, 43:865-876.
6. Kamischke A., Nieschlag E. Progress towards hormonal male contraception. Trends Pharmacol Sci 2004, 25:49-57.
7. Gao W., Dalton J.T. Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today 2007, 12:421-428.
8. Thevis M., Geyer H., Kamber M., Schänzer W. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Drug Test Anal 2009, 1:387-392.
9. Grata E., Perrenoud L., Saugy M., Baume N. SARM-S4 and metabolites detection in sports drug testing: a case report. Forensic Sci Int 2011, 213:104-108.
10. Scarth J.P., Spencer H.A., Timbers S.E., Hudson S.C., Hillyer L.L. The use of in vitro technologies coupled with high resolution accurate mass LC-MS for studying drug metabolism in equine drug surveillance. Drug Test Anal 2010, 2:1-10.
11. Scarth J.P., Teale P., Kuuranne T. Drug metabolism in the horse: a review. Drug Test Anal 2011, 3:19-53.
12. Tucker H., Chesterson G.J. Resolution of the nonsteroidal antiandrogen 4'-cyano-3-([fluorophenyl]sulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)-propionanilide and the determination of the absolute configuration of the active enantiomer. J Med Chem 1988, 31:885-887.
13. Tucker H., Crook J.W., Chesterson G.J. Nonsteroidal antiandrogens. Synthesis and structur-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. J Med Chem 1988, 31:954-959.
14. Marhefka C.A., Gao W., Chung K., Kim J., He Y., Yin D., et al. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators. J Med Chem 2004, 47:993-998.
15. Thevis M., Kamber M., Schänzer W. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun Mass Spectrom 2006, 20:870-876.
16. Kuuranne T., Leinonen A., Schänzer W., Kamber M., Kostiainen R., Thevis M. Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of in vitro synthesized metabolites for doping control purposes. Drug Metab Dispos 2008, 36:571-581.
17. Thevis M., Thomas A., Fußhöller G., Beuck S., Geyer H., Schänzer W. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S4) for routine doping control purposes. Rapid Commun Mass Spectrom 2010, 24:2245-2254.
18. Thevis M., Thomas A., Kohler M., Beuck S., Schänzer W. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis. J Mass Spectrom 2009, 44:442-460.